Pub Date : 2024-10-16DOI: 10.1016/j.soard.2024.10.002
{"title":"Cartoon","authors":"","doi":"10.1016/j.soard.2024.10.002","DOIUrl":"10.1016/j.soard.2024.10.002","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 11","pages":"Page 1182"},"PeriodicalIF":3.5,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142437937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-16DOI: 10.1016/j.soard.2024.10.001
{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 20, November 2024","authors":"","doi":"10.1016/j.soard.2024.10.001","DOIUrl":"10.1016/j.soard.2024.10.001","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 11","pages":"Pages 1179-1181"},"PeriodicalIF":3.5,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142437936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-09DOI: 10.1016/j.soard.2024.08.027
{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 20, October 2024","authors":"","doi":"10.1016/j.soard.2024.08.027","DOIUrl":"10.1016/j.soard.2024.08.027","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 10","pages":"Pages 987-989"},"PeriodicalIF":3.5,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142162044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-09DOI: 10.1016/j.soard.2024.08.028
{"title":"Cartoon","authors":"","doi":"10.1016/j.soard.2024.08.028","DOIUrl":"10.1016/j.soard.2024.08.028","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 10","pages":"Page 990"},"PeriodicalIF":3.5,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142162045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-30DOI: 10.1016/j.soard.2024.08.029
Reyhaneh Yousefi M.Sc., Tair Ben-Porat Ph.D., Ariany Marques Vieira M.Sc., Kim L. Lavoie Ph.D., Simon L. Bacon Ph.D., REBORN Study Team, S.L. Bacon, K.L. Lavoie, A. Gautier, P. Marion, A. Alberga, R. Denis, P. Garneau, G. Lavigne, R. Pescarus, S. Raymond-Carrier, S. Santosa, A.S. Studer, T. Ben-Porat, K. Delaney, A. Fortin, C. Julien, L. Mercier, R. Woods, R. Yousef
Prioritizing patients for metabolic and bariatric surgery (MBS) based on their potential postoperative benefits is essential. To examine changes in quality of life (QoL) during the initial postoperative year among patients with diverse eligibility statuses and determine which group experiences greater benefits. Center intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de- Montréal (CIUSSS-NIM), Canada. We categorized patients into 3 groups based on obesity class and the presence of comorbidities: Group 1 (obesity class II without comorbidities, n = 28); Group 2 (obesity class II with comorbidities, n = 36); and Group 3 (obesity class III, n = 460). QoL (Short-Form QoL questionnaire [SF-12]) and anthropometrics were measured at 6 months before, and 6 and 12 months after surgery. Repeated measures mixed models revealed a significant main effect of time ( < .001) and an interaction between time and group for the physical component of QoL ( = .007). These indicated consistent improvements across time in all groups, with the greatest benefits seen in Group 3 relative to Group 1. There were no interactions between time and group for the mental components of QoL ( = .402). There were significant interaction effects for weight and BMI (p’s < .001), with Group 3 losing more weight than Groups 1 or 2. All groups that underwent MBS had improvements in the physical aspects of QoL and weight over time, even those who have traditionally not be considered eligible for MBS (i.e., Group 1). This provides a starting point to explore the importance of not excluding patients due to their weight and comorbidity status and setting comprehensive eligibility criteria encompassing all patients who might benefit from MBS, beyond just weight loss.
根据代谢和减肥手术（MBS）患者术后可能获得的益处确定其优先顺序至关重要。目的：研究不同资格的患者在术后最初一年中生活质量（QoL）的变化，并确定哪一组患者能获得更大的益处。加拿大蒙特利尔北岛健康与社会服务综合大学中心（CIUSSS-NIM）。我们根据肥胖程度和是否存在合并症将患者分为三组：第 1 组（无合并症的 II 类肥胖，n = 28）；第 2 组（有合并症的 II 类肥胖，n = 36）；第 3 组（III 类肥胖，n = 460）。在手术前 6 个月、手术后 6 个月和 12 个月测量了 QoL（短式 QoL 问卷 [SF-12]）和人体测量学指标。重复测量混合模型显示，对于 QoL 的身体部分，时间具有显著的主效应（< .001），时间与组别之间存在交互作用（= .007）。在 QoL 的心理因素方面，时间与组别之间没有交互作用 ( = .402)。体重和体重指数之间存在明显的交互作用（P<0.001），第三组比第一组或第二组减重更多。随着时间的推移，接受心理健康教育的所有组别在身体方面的 QoL 和体重都有所改善，即使是那些传统上被认为不符合心理健康教育条件的组别（即第 1 组）也是如此。这为我们提供了一个起点，以探讨不因体重和并发症状况而将患者排除在外的重要性，以及制定全面的资格标准的重要性，这些标准包括所有可能受益于 MBS 的患者，而不仅仅是体重减轻的患者。
{"title":"Who gains the most quality-of-life benefits from metabolic and bariatric surgery: findings from the prospective REBORN cohort study","authors":"Reyhaneh Yousefi M.Sc., Tair Ben-Porat Ph.D., Ariany Marques Vieira M.Sc., Kim L. Lavoie Ph.D., Simon L. Bacon Ph.D., REBORN Study Team, S.L. Bacon, K.L. Lavoie, A. Gautier, P. Marion, A. Alberga, R. Denis, P. Garneau, G. Lavigne, R. Pescarus, S. Raymond-Carrier, S. Santosa, A.S. Studer, T. Ben-Porat, K. Delaney, A. Fortin, C. Julien, L. Mercier, R. Woods, R. Yousef","doi":"10.1016/j.soard.2024.08.029","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.029","url":null,"abstract":"Prioritizing patients for metabolic and bariatric surgery (MBS) based on their potential postoperative benefits is essential. To examine changes in quality of life (QoL) during the initial postoperative year among patients with diverse eligibility statuses and determine which group experiences greater benefits. Center intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de- Montréal (CIUSSS-NIM), Canada. We categorized patients into 3 groups based on obesity class and the presence of comorbidities: Group 1 (obesity class II without comorbidities, n = 28); Group 2 (obesity class II with comorbidities, n = 36); and Group 3 (obesity class III, n = 460). QoL (Short-Form QoL questionnaire [SF-12]) and anthropometrics were measured at 6 months before, and 6 and 12 months after surgery. Repeated measures mixed models revealed a significant main effect of time ( < .001) and an interaction between time and group for the physical component of QoL ( = .007). These indicated consistent improvements across time in all groups, with the greatest benefits seen in Group 3 relative to Group 1. There were no interactions between time and group for the mental components of QoL ( = .402). There were significant interaction effects for weight and BMI (p’s < .001), with Group 3 losing more weight than Groups 1 or 2. All groups that underwent MBS had improvements in the physical aspects of QoL and weight over time, even those who have traditionally not be considered eligible for MBS (i.e., Group 1). This provides a starting point to explore the importance of not excluding patients due to their weight and comorbidity status and setting comprehensive eligibility criteria encompassing all patients who might benefit from MBS, beyond just weight loss.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"6 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142258957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-27DOI: 10.1016/j.soard.2024.08.023
{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 20, September 2024","authors":"","doi":"10.1016/j.soard.2024.08.023","DOIUrl":"10.1016/j.soard.2024.08.023","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 9","pages":"Pages 890-892"},"PeriodicalIF":3.5,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142083518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-27DOI: 10.1016/j.soard.2024.08.024
{"title":"Cartoon","authors":"","doi":"10.1016/j.soard.2024.08.024","DOIUrl":"10.1016/j.soard.2024.08.024","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 9","pages":"Page 893"},"PeriodicalIF":3.5,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142083519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-27DOI: 10.1016/j.soard.2024.08.025
Caren Mangarelli M.D. M.S., Gillian Fell M.D., Emily Hobbs M.S. R.D.N. L.D.N., Kelly Walker Lowry Ph.D., Elissa Williams M.S. A.P.R.N.-F.P.A. C.P.N.P.-P.C., Janey S.A. Pratt M.D. F.A.C.S. F.A.S.M.B.S.
The standard of care for pediatric patients with severe obesity considering metabolic and bariatric surgery is a preoperative multidisciplinary evaluation. A multidisciplinary team allows for the efficient use of variable personnel expertise to evaluate, manage, and support a pediatric patient and family through metabolic and bariatric surgery. This review discusses the purpose, recommended team members, patient selection, content, and benefits of the multidisciplinary preoperative evaluation. This evaluation should reduce barriers to care and optimize patient safety and outcomes while taking into consideration the unique developmental needs of this age group.
{"title":"Pediatric metabolic and bariatric surgery: indications and preoperative multidisciplinary evaluation","authors":"Caren Mangarelli M.D. M.S., Gillian Fell M.D., Emily Hobbs M.S. R.D.N. L.D.N., Kelly Walker Lowry Ph.D., Elissa Williams M.S. A.P.R.N.-F.P.A. C.P.N.P.-P.C., Janey S.A. Pratt M.D. F.A.C.S. F.A.S.M.B.S.","doi":"10.1016/j.soard.2024.08.025","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.025","url":null,"abstract":"The standard of care for pediatric patients with severe obesity considering metabolic and bariatric surgery is a preoperative multidisciplinary evaluation. A multidisciplinary team allows for the efficient use of variable personnel expertise to evaluate, manage, and support a pediatric patient and family through metabolic and bariatric surgery. This review discusses the purpose, recommended team members, patient selection, content, and benefits of the multidisciplinary preoperative evaluation. This evaluation should reduce barriers to care and optimize patient safety and outcomes while taking into consideration the unique developmental needs of this age group.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142258916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-24DOI: 10.1016/j.soard.2024.08.026
Sebastian Storms, Grace H. Oberhoff, Lena Schooren, Andreas Kroh, Alexander Koch, Karl-Peter Rheinwalt, Florian W.R. Vondran, Ulf P. Neumann, Patrick H. Alizai, Sophia M.-T. Schmitz
Most patients undergoing bariatric surgery demonstrate elements of the metabolic syndrome (MetS) and can therefore be diagnosed with metabolically unhealthy obesity (MUO). Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) as hepatic manifestations of the MetS occur in many patients with obesity, but their leverage on postoperative improvement to Metabolic Health (MH), defined as absence of any metabolic comorbidity, remains unclear. The aim of this study was to assess the influence of liver health status, operative procedure, and sex on postoperative switch from a MUO to an MH phenotype. Secondary objective was weight loss to MH. University Hospital, Germany. Patients who underwent either Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) at our obesity surgery center were included in this retrospective study. Liver biopsy was taken and evaluated for presence of NAFLD/NASH. For diagnosis of MH, blood pressure and laboratory values referring to the MetS were assessed preoperatively and at 3, 6, 12, and 24 months’ postoperatively. One hundred thirty-three patients (73% female) with a mean body mass index of 52.0 kg/m and mean age of 43 years were included in this study. A total of 55.6% underwent RYGB and 44.4% underwent SG. NAFLD was found in 51.1% of patients and NASH in 33.8%. All patients were diagnosed MUO at baseline. Postoperatively, 38.3% patients (n = 51) switched to a MH condition. Mean time to MH was 321 days and mean excess body mass index loss to MH was 63.8%. There were no differences regarding liver health status, operative procedure, or sex. Bariatric surgery can resolve MUO independent of liver health status, operative procedure, and sex. However, patients should be closely monitored to ensure sustainable long-term outcomes following the switch to the MH condition.
{"title":"Preoperative nonalcoholic steatohepatitis and resolution of metabolic comorbidities after bariatric surgery","authors":"Sebastian Storms, Grace H. Oberhoff, Lena Schooren, Andreas Kroh, Alexander Koch, Karl-Peter Rheinwalt, Florian W.R. Vondran, Ulf P. Neumann, Patrick H. Alizai, Sophia M.-T. Schmitz","doi":"10.1016/j.soard.2024.08.026","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.026","url":null,"abstract":"Most patients undergoing bariatric surgery demonstrate elements of the metabolic syndrome (MetS) and can therefore be diagnosed with metabolically unhealthy obesity (MUO). Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) as hepatic manifestations of the MetS occur in many patients with obesity, but their leverage on postoperative improvement to Metabolic Health (MH), defined as absence of any metabolic comorbidity, remains unclear. The aim of this study was to assess the influence of liver health status, operative procedure, and sex on postoperative switch from a MUO to an MH phenotype. Secondary objective was weight loss to MH. University Hospital, Germany. Patients who underwent either Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) at our obesity surgery center were included in this retrospective study. Liver biopsy was taken and evaluated for presence of NAFLD/NASH. For diagnosis of MH, blood pressure and laboratory values referring to the MetS were assessed preoperatively and at 3, 6, 12, and 24 months’ postoperatively. One hundred thirty-three patients (73% female) with a mean body mass index of 52.0 kg/m and mean age of 43 years were included in this study. A total of 55.6% underwent RYGB and 44.4% underwent SG. NAFLD was found in 51.1% of patients and NASH in 33.8%. All patients were diagnosed MUO at baseline. Postoperatively, 38.3% patients (n = 51) switched to a MH condition. Mean time to MH was 321 days and mean excess body mass index loss to MH was 63.8%. There were no differences regarding liver health status, operative procedure, or sex. Bariatric surgery can resolve MUO independent of liver health status, operative procedure, and sex. However, patients should be closely monitored to ensure sustainable long-term outcomes following the switch to the MH condition.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"23 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142258915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-19DOI: 10.1016/j.soard.2024.08.021
Yulia Petriuk B.Sc., Shlomi Rayman M.D., Reut El-On M.D., Danit Dayan, Shai Eldar M.D., Adam Abu Abeid M.D., Andrei Keidar M.D.
Failed sleeve gastrectomy (SG), defined by inadequate weight loss or weight regain and by reflux and structural complications, can be treated by a laparoscopic conversion to Roux-en-Y gastric bypass (RYGB). To examine the efficacy and outcomes of conversion surgery over a 14-year follow-up period. Government and private medical centers in university settings. We conducted a cohort study of 58 patients who underwent conversion of SG to RYGB for 2 indications: invalidating reflux or weight recurrence during 2009–2023. Weight dynamics analysis was performed with 2 references of weight: before SG (with intention to treat) and before conversion. At conversion surgery, the mean weight, body mass index (BMI), percentage of excess weight loss (%EWL), and percentage of total weight loss (%TWL) (calculated with intention to treat, from the weight before SG) were 92.2 ± 25.2 kg, 34.3 ± 8.0 kg/m, 55.2% ± 39.9%, and 22.8% ± 15.2%, respectively. Mean nadir weight, BMI, %EWL, and %TWL after conversion (calculated from the weight before SG) were 71.1 ± 18.4 kg, 26.7 ± 5.5 kg/m, 96.5% ± 30.5%, and 40.2% ± 10.6%, respectively. At follow-up, the mean weight, BMI, %EWL, and %TWL (calculated from the weight before SG) were 80.4 ± 17.7 kg, 29.6 ± 5.4 kg/m, 78.9% ± 26.8%, and 33.3% ± 11.2%, respectively. The mean percentages of %EWLio and %TWLio (calculated from the weight before conversion = EWL from index operation) at nadir were 73.2% ± 92.7% and 20.1% ± 12.2% after conversion, respectively, and decreased to 41.9% ± 94.0% and 13.2% ± 15.2% at last follow-up (mean 6.6 yr), respectively. SG to RYGB conversion provides moderate to low complementary weight loss in the short term. By 3–4 years, there is a clear trend toward weight gain.
{"title":"Conversion of sleeve gastrectomy to Roux-en-Y laparoscopic gastric bypass: a comprehensive 14-year follow-up study on efficacy and outcomes","authors":"Yulia Petriuk B.Sc., Shlomi Rayman M.D., Reut El-On M.D., Danit Dayan, Shai Eldar M.D., Adam Abu Abeid M.D., Andrei Keidar M.D.","doi":"10.1016/j.soard.2024.08.021","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.021","url":null,"abstract":"Failed sleeve gastrectomy (SG), defined by inadequate weight loss or weight regain and by reflux and structural complications, can be treated by a laparoscopic conversion to Roux-en-Y gastric bypass (RYGB). To examine the efficacy and outcomes of conversion surgery over a 14-year follow-up period. Government and private medical centers in university settings. We conducted a cohort study of 58 patients who underwent conversion of SG to RYGB for 2 indications: invalidating reflux or weight recurrence during 2009–2023. Weight dynamics analysis was performed with 2 references of weight: before SG (with intention to treat) and before conversion. At conversion surgery, the mean weight, body mass index (BMI), percentage of excess weight loss (%EWL), and percentage of total weight loss (%TWL) (calculated with intention to treat, from the weight before SG) were 92.2 ± 25.2 kg, 34.3 ± 8.0 kg/m, 55.2% ± 39.9%, and 22.8% ± 15.2%, respectively. Mean nadir weight, BMI, %EWL, and %TWL after conversion (calculated from the weight before SG) were 71.1 ± 18.4 kg, 26.7 ± 5.5 kg/m, 96.5% ± 30.5%, and 40.2% ± 10.6%, respectively. At follow-up, the mean weight, BMI, %EWL, and %TWL (calculated from the weight before SG) were 80.4 ± 17.7 kg, 29.6 ± 5.4 kg/m, 78.9% ± 26.8%, and 33.3% ± 11.2%, respectively. The mean percentages of %EWLio and %TWLio (calculated from the weight before conversion = EWL from index operation) at nadir were 73.2% ± 92.7% and 20.1% ± 12.2% after conversion, respectively, and decreased to 41.9% ± 94.0% and 13.2% ± 15.2% at last follow-up (mean 6.6 yr), respectively. SG to RYGB conversion provides moderate to low complementary weight loss in the short term. By 3–4 years, there is a clear trend toward weight gain.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"102 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142219341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：